Durect Corp (NAS:DRRX)
$ 1.06 -0.07 (-6.19%) Market Cap: 32.90 Mil Enterprise Value: 23.96 Mil PE Ratio: 0 PB Ratio: 2.18 GF Score: 52/100

Q4 2018 DURECT Corp Earnings Call Transcript

Mar 07, 2019 / 09:30PM GMT
Release Date Price: $6.7 (-5.79%)
Operator

Greetings, and welcome to the DURECT Corporation Fourth Quarter and Full Year 2018 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mike Arenberg, Chief Financial Officer for DURECT Corporation. Thank you. You may begin.

Michael H. Arenberg
DURECT Corporation - CFO

Good afternoon, and welcome to our fourth quarter 2018 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. I will provide a brief review of our financial results and then Jim Brown, our President and CEO, will provide a business update. We will then open up the call for a question-and-answer session.

Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products in development; expected product benefits; our development plans; future clinical trials; or projected financial results. These forward-looking statements involve risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot